OCHOA AUGUSTO C has a total of 16 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Australia, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are COPENHAGEN UNIVERSITY, NAUTILUS BIOTECH and LARSEN BJARNE DUE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Israel | 2 | |
#5 | Japan | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | South Africa | 2 | |
#8 | Ireland | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Longo Dan L | 13 |
#2 | Ochoa Augusto C | 13 |
#3 | O'Shea John J | 7 |
#4 | Ghosh Paritosh | 7 |
#5 | Mizoguchi Hiromoto | 7 |
#6 | Young Howard A | 7 |
#7 | Loeffler Cynthia M | 6 |
#8 | Urba Walter | 6 |
#9 | Loeffler Cynthia | 6 |
#10 | Dan L Longo | 1 |
Publication | Filing date | Title |
---|---|---|
IL105326D0 | Soluble immunosuppressive factor,genes encoding the same and screening agents inhibiting or reversing the action thereof | |
IE922233A1 | Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity |